These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 30546364)

  • 1. Host Regulators of Liver Fibrosis During Human Schistosomiasis.
    Kamdem SD; Moyou-Somo R; Brombacher F; Nono JK
    Front Immunol; 2018; 9():2781. PubMed ID: 30546364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of innate immune mediators are associated with liver fibrosis in low parasite burden Schistosoma mansoni-infected individuals.
    Rodrigues Oliveira JL; Teixeira MM; Lambertucci JR; Antunes CMF; Carneiro M; Negrão-Corrêa D
    Scand J Immunol; 2018 Mar; 87(3):. PubMed ID: 29363152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection.
    Caldas IR; Campi-Azevedo AC; Oliveira LF; Silveira AM; Oliveira RC; Gazzinelli G
    Acta Trop; 2008; 108(2-3):109-17. PubMed ID: 18577364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of immune responses of Schistosoma mansoni-infected mice with distinct chronic forms of the disease.
    Silva LM; Oliveira SA; Ribeiro-dos-Santos R; Andrade ZA; Soares MB
    Acta Trop; 2004 Jul; 91(2):189-96. PubMed ID: 15234668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder morbidity and hepatic fibrosis in mixed Schistosoma haematobium and S. mansoni Infections: a population-wide study in Northern Senegal.
    Meurs L; Mbow M; Vereecken K; Menten J; Mboup S; Polman K
    PLoS Negl Trop Dis; 2012; 6(9):e1829. PubMed ID: 23029589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Role of HMGB1 in the Pathogenesis of Schistosomiasis Liver Fibrosis.
    Vicentino ARR; Carneiro VC; Allonso D; Guilherme RF; Benjamim CF; Dos Santos HAM; Xavier F; Pyrrho ADS; Gomes JAS; Fonseca MC; de Oliveira RC; Pereira TA; Ladislau L; Lambertucci JR; Fantappié MR
    Front Immunol; 2018; 9():1979. PubMed ID: 30258438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Schistosoma mansoni-specific IgG and IgE antibody production and clinical schistosomiasis status in a rural area of Minas Gerais, Brazil.
    Negrão-Corrêa D; Fittipaldi JF; Lambertucci JR; Teixeira MM; Antunes CM; Carneiro M
    PLoS One; 2014; 9(2):e88042. PubMed ID: 24505371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital exposure to Schistosoma mansoni infection: impact on the future immune response and the disease outcome.
    Othman AA; Shoheib ZS; Saied EM; Soliman RH
    Immunobiology; 2010; 215(2):101-12. PubMed ID: 19457572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of schistosome antibodies with hepatosplenic signs and symptoms among patients from Kaoma, Western Province, Zambia.
    Payne L; Turner-Moss E; Mutengo M; Asombang AW; Kelly P
    BMC Res Notes; 2013 Aug; 6():344. PubMed ID: 23987918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental models of Schistosoma mansoni infection.
    Cheever AW; Lenzi JA; Lenzi HL; Andrade ZA
    Mem Inst Oswaldo Cruz; 2002 Oct; 97(7):917-40. PubMed ID: 12471417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection.
    de Jesus AR; Magalhães A; Miranda DG; Miranda RG; Araújo MI; de Jesus AA; Silva A; Santana LB; Pearce E; Carvalho EM
    Infect Immun; 2004 Jun; 72(6):3391-7. PubMed ID: 15155645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of IL-9, IL-10, and IL-17 Cytokines With Hepatic Fibrosis in Human
    Franco KGS; de Amorim FJR; Santos MA; Rollemberg CVV; de Oliveira FA; França AVC; Santos CNO; Magalhães LS; Cazzaniga RA; de Lima FS; Benevides L; Carregaro V; Silva JS; Brito HLF; Fernandes DA; da Silva ÂM; de Almeida RP; Bezerra-Santos M; de Jesus AR
    Front Immunol; 2021; 12():779534. PubMed ID: 34970264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological indicators of morbidity in human schistosomiasis mansoni: role of vascular endothelial growth factor and anti-soluble egg antigen IgG4 in disease progression.
    Tawfeek GM; Alafifi AM; Azmy MF
    J Egypt Soc Parasitol; 2003 Aug; 33(2):597-614. PubMed ID: 14964670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of early liver fibrosis in patients with intestinal schistosomiasis: sonographic and histologic findings in Schistosoma mansoni infection.
    Chiavaroli R; Grima P; Grima P
    Infection; 2008 Dec; 36(6):585-9. PubMed ID: 18998054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal schistosomiasis of Ijinga Island, north-western Tanzania: prevalence, intensity of infection, hepatosplenic morbidities and their associated factors.
    Mueller A; Fuss A; Ziegler U; Kaatano GM; Mazigo HD
    BMC Infect Dis; 2019 Oct; 19(1):832. PubMed ID: 31590657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophil activation status, cytokines and liver fibrosis in Schistosoma mansoni infected patients.
    Silveira-Lemos D; Teixeira-Carvalho A; Martins-Filho OA; Alves Oliveira LF; Costa-Silva MF; Matoso LF; de Souza LJ; Gazzinelli A; Corrêa-Oliveira R
    Acta Trop; 2008; 108(2-3):150-9. PubMed ID: 18550021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of serum levels of IL-9 and IL-17 in human Schistosoma mansoni infection and their relationship with periportal fibrosis.
    Barreto AV; Lacerda GA; Figueiredo AL; Diniz GT; Gomes EC; Domingues AL; Barbosa CS; Montengro SM; Morais CN
    Immunobiology; 2016 Dec; 221(12):1351-1354. PubMed ID: 27506138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine profile associated with human chronic schistosomiasis mansoni.
    Magalhães A; Miranda DG; Miranda RG; Araújo MI; Jesus AA; Silva A; Santana LB; Pearce E; Carvalho EM; Jesus AR
    Mem Inst Oswaldo Cruz; 2004; 99(5 Suppl 1):21-6. PubMed ID: 15486630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans.
    Alves Oliveira LF; Moreno EC; Gazzinelli G; Martins-Filho OA; Silveira AM; Gazzinelli A; Malaquias LC; LoVerde P; Leite PM; Correa-Oliveira R
    Infect Immun; 2006 Feb; 74(2):1215-21. PubMed ID: 16428771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of Schistosoma mansoni Circulating Antigen in Chronic Hepatitis C Patients with Different Stages of Liver Fibrosis.
    Attallah AM; El-Far M; Omran MM; Farid K; Attallah AA; Abd-Elaziz D; El-Bendary MS; El-Dosoky I; Ismail H
    J Immunoassay Immunochem; 2016; 37(3):316-30. PubMed ID: 26745203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.